Haplotype of the BRCA2 6857delAA mutation in 4 families with breast/ovarian cancer;Análisis del haplotipo en portadores de la mutación 6857delAA en el gen BRCA2 en 4 familias con cáncer de mama u ovario hereditario

Medicina Clinica

Volumn 123, Issue 14, 2004, Pages 543-545

  Campos, Berta ^a   Díez, Orland ^a   Álvarez, Carolina ^b   Palma, Lorena ^b   Domènech, Montserrat ^a   Balmaña, Judith ^a   Sanz, Judit ^a   Ramírez, Amaya ^a   Alonso, Carmen ^a   Carvallo, Pilar ^b   Baiget, Montserrat ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

BRCA2; Haplotype; Hereditary breast cancer; Recurrent mutation

Indexed keywords

BRCA2 PROTEIN;

ALLELE; ARTICLE; BREAST CANCER; CHILE; CHROMOSOME; CONTROLLED STUDY; DNA FLANKING REGION; FAMILIAL CANCER; GENE MUTATION; GENETIC SCREENING; HAPLOTYPE; HETEROZYGOTE; HUMAN; MICROSATELLITE MARKER; OVARY CANCER; SPAIN;

EID: 9344232718     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13067548     Document Type: Article

References (16)

1. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994;266:66-71.
2. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995; 378:789-92.
3. Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 1998;62:676-89.
4. BIC: Disponible en: hhtp://www.nchgr.nih.gov/ Intramural_research/ Labtransfer/Bic
5. Velasco E, Esteban E, Infante M, Durán M, Lastra E, García C, et al. Estudio molecular en los genes BRCA1 y BRCA2 en 153 familias con cancer de mama de Castilla y León (España): identificación de nueve variantes de efecto desconocido no descritas. Med Clin (Barc) 2002; 119:441-5.
6. Roa BB, Boyd AA, Vocik K, Richards CS. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat Genet 1996;14:185-7.
7. Thorlacius S, Olafsdottir G, Tryggvadottir L Neuhausen S, Jonasson JG, Tavtigian SV, et al. A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nat Genet 1996;13:117-9.
8. Szabo CI, King MC. Population genetics of BRCA1 and BRCA2. Am J Hum Genet 1997; 60:1013-20.
9. Neuhausen SL. Founder populations and their uses for breast cancer genetics. Breast Cancer Res 2000;2:77-81.
10. Díez O, Del Río E, Sanz J, Cortés J, Brunet J, Alonso MC, et al. Identificación de una nueva mutación en el gen BRCA2 mediante analisis de la proteína truncada en una familia española con cáncer de mama hereditario. Med Clin (Barc) 1999;112:179-81.
11. Díez O, Cortés J, Domènech M, Pericay C, Brunet J, Alonso C, et al BRCA2 germ-line mutations in male breast cancer patients. Ann Oncol 2000;11:1-4.
12. Carvallo M, Palma L, Gallardo M, Rousseau C, King M. Analysis of mutations in the BRCA2 gene in Chilean families with breast cancer. Eur J Hum Genet 2002;10(Suppl 1):84.
13. Vega A, Campos B, Bressac-de-Paillerets B, Bond PM, Janin N, Douglas FS, et al. The R71G BRCA1 is a founder Spanish mutation and leads to aberrant splicing of the transcript. Hum Mutat 2001;17:520-1.
14. Campos C, Díez O, Odefrey F, Domènech M, Moncoutier V, Martínez-Ferrandis JI, et al. Haplotype analysis of the BRCA2 9254delATCAT recurrent mutation in breast/ovarian cancer families originated from Spain. Hum Mutat 2003; 21:452.
15. Vega A, Torres M, Martínez JI, Ruiz-Ponte C, Barros F, Carracedo A. Analysis of BRCA1 and BRCA2 in breast and breast/ovarian cancer families shows population substructure in the Iberian peninsula. Ann Hum Genet 2002;66:29-36.
16. Ruiz-Flores P, Sinilnikova OM, Badzioch M, Calderon-Garcidueñas AL, Chopin S, Fabrice O, et al. BRCA1 and BRCA2 mutation analysis of early-onset and familial breast cancer cases in Mexico. Hum Mutat 2002;20:474-5.